181 related articles for article (PubMed ID: 9827687)
1. Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy.
Conzone SD; Häfeli UO; Day DE; Ehrhardt GJ
J Biomed Mater Res; 1998 Dec; 42(4):617-25. PubMed ID: 9827687
[TBL] [Abstract][Full Text] [Related]
2. Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
Häfeli UO; Casillas S; Dietz DW; Pauer GJ; Rybicki LA; Conzone SD; Day DE
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):189-99. PubMed ID: 10219814
[TBL] [Abstract][Full Text] [Related]
3. [In situ therapy of deep-seated canver by radioactive microspheres].
Kawashita M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 May; 58(5):585-91. PubMed ID: 12520226
[No Abstract] [Full Text] [Related]
4. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
[TBL] [Abstract][Full Text] [Related]
5. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.
Häfeli UO; Pauer GJ; Unnithan J; Prayson RA
Eur J Pharm Biopharm; 2007 Mar; 65(3):282-8. PubMed ID: 17129715
[TBL] [Abstract][Full Text] [Related]
6. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
7. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?
McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB
J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592
[TBL] [Abstract][Full Text] [Related]
8. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
9. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
Ho S; Lau WY; Leung WT
Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
[No Abstract] [Full Text] [Related]
10. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
Chiesa C; Mira M; Maccauro M; Romito R; Spreafico C; Sposito C; Bhoori S; Morosi C; Pellizzari S; Negri A; Civelli E; Lanocita R; Camerini T; Bampo C; Carrara M; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):503-8. PubMed ID: 23358402
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Activity Lost to Delivery-System Residual and Decay in Yttrium-90 Radioembolization.
Hoang NS; Khalaf MH; Rosenberg JK; Kwofie J; Reposar AL; Wang DS; Louie JD; Sze DY
J Vasc Interv Radiol; 2018 Dec; 29(12):1672-1677. PubMed ID: 30316674
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.
Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828
[No Abstract] [Full Text] [Related]
13. Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.
Fallahpoor M; Abbasi M; Parach AA; Kalantari F
J Appl Clin Med Phys; 2017 Mar; 18(2):176-180. PubMed ID: 28300366
[TBL] [Abstract][Full Text] [Related]
14. Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities.
Hashikin NA; Yeong CH; Abdullah BJ; Ng KH; Chung LY; Dahalan R; Perkins AC
PLoS One; 2015; 10(9):e0138106. PubMed ID: 26382059
[TBL] [Abstract][Full Text] [Related]
15. Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer.
Kawashita M; Shineha R; Kim HM; Kokubo T; Inoue Y; Araki N; Nagata Y; Hiraoka M; Sawada Y
Biomaterials; 2003 Aug; 24(17):2955-63. PubMed ID: 12742735
[TBL] [Abstract][Full Text] [Related]
16. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method.
Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253
[TBL] [Abstract][Full Text] [Related]
17. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
18. Combination Ipsilateral Lobar and Segmental Radioembolization Using Glass Yttrium-90 Microspheres for Treatment of Multifocal Hepatic Malignancies.
Arslan B; Padela MT; Madassery S; Masrani A; Tasse J; Supanich M; Ahmed O
J Vasc Interv Radiol; 2018 Aug; 29(8):1110-1116. PubMed ID: 30055781
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.
Ibrahim SM; Lewandowski RJ; Sato KT; Gates VL; Kulik L; Mulcahy MF; Ryu RK; Omary RA; Salem R
World J Gastroenterol; 2008 Mar; 14(11):1664-9. PubMed ID: 18350597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
